Back to Search
SUCHETA TELANG, MD
MD
Neonatal-Perinatal Medicine Physician
NPI: 1528030483Individual
Specialties, Licenses & Credentials
Pediatrics — Neonatal-Perinatal Medicine
Code: 2080N0001X
37099(KY)
Research & Publications (20)
Depletion of ascorbic acid restricts angiogenesis and retards tumor growth in a mouse model.
PMID 17325743·Neoplasia·2007
7-preclinical
Ras transformation requires metabolic control by 6-phosphofructo-2-kinase.
PMID 16715124·Oncogene·2006
7-preclinical
Fortifying fresh human milk with commercial powdered human milk fortifiers does not affect bacterial growth during 6 hours at room temperature.
PMID 16183356·J Am Diet Assoc·2005
8-other
Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype.
PMID 19341623·Cell Stem Cell·2009
7-preclinical
Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases.
PMID 19473963·J Biol Chem·2009
8-other
Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer.
PMID 19454274·Exp Mol Pathol·2009
6-review
E-Cadherin truncation and sialyl Lewis-X overexpression in oral squamous cell carcinoma and oral precancerous conditions.
PMID 19152244·Neoplasma·2009
8-other
Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.
PMID 18202014·Mol Cancer Ther·2008
7-preclinical
Targeting aspartate aminotransferase in breast cancer.
PMID 18922152·Breast Cancer Res·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 231 E CHESTNUT ST
LOUISVILLE, KY 40202 - Phone
- (502) 588-0982
Quick Facts
- NPI
- 1528030483
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile